Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/221140
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lozano Garcia, Ester | - |
dc.contributor.author | Mena, Mari-Pau | - |
dc.contributor.author | Díaz Sánchez, Tania | - |
dc.contributor.author | Rosiñol Dachs, Laura | - |
dc.date.accessioned | 2025-05-20T13:50:47Z | - |
dc.date.available | 2025-05-20T13:50:47Z | - |
dc.date.issued | 2025-04 | - |
dc.identifier.issn | 2051-1426 | - |
dc.identifier.uri | https://hdl.handle.net/2445/221140 | - |
dc.description.abstract | Presence of plate-bound PVR or nectin-2 at 2 µg/mL did not significantly modify cell viability nor frequency of proliferating cells compared to isotype control. As expected, Treg conditions significantly increased FoxP3 expression (paired T test p<0.0001, n=6) which was accompanied by elevation of CD226 levels (p=0.0026). Surprisingly, Treg conditions led to reduction of TIGIT expression (p=0.0039) and CD96 (p=0.084). In addition, PVR ligation resulted in a higher frequency of IL10-producing cells in Th0 conditions (p=0.0193), most of them expressing high levels of CD226 (78.48% ± 2.324), CD96 (59.87% ± 4.032), and to a lesser extent, TIGIT (39.82% ± 4.043). Consistently, under these experimental conditions dual blockade of TIGIT and CD96 did not abrogate the increase in the percentage of IL-10 producing cells, suggesting that PVR binds CD226 expressing cells to upregulate IL-10 production. | - |
dc.format.extent | 1 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BMJ Publishing Group | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1136/jitc-2025-ITOC11.16 | - |
dc.relation.ispartof | Journal for ImmunoTherapy of Cancer, 2025, vol. 13, num.Supplement 1, p. A10-A10 | - |
dc.relation.uri | https://doi.org/10.1136/jitc-2025-ITOC11.16 | - |
dc.rights | cc-by-nc (c) Lozano Garcia, Ester et al., 2025 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | - |
dc.source | Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia) | - |
dc.subject.classification | Cèl·lules T | - |
dc.subject.classification | Mieloma múltiple | - |
dc.subject.other | T cells | - |
dc.subject.other | Multiple myeloma | - |
dc.title | PVR–CD226 interaction regulates IL-10 production during human T cell differentiation | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 758016 | - |
dc.date.updated | 2025-05-20T13:50:48Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
892294.pdf | 61.48 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License